Endometriosis, Sexual Dysfunction
Conditions
Brief summary
This study aimed to assess the effects of dydrogesterone on sexual function in women with endometriosis using Female Function Sexual Index (FSFI).
Detailed description
Sexual dysfunction is an important outcome for patients with endometriosis. In this study, we compare the fsfi (female sexual function index) questions and the scores before and after dydrogesterone treatment in patients with endometriosis. We aim to measure the effect of dydrogesterone in patients with endometriosis.
Interventions
DRUGDydrogesterone
79 women, aged between 18 and 45 years, who were examined at our tertiary gynecology outpatient clinic between April 2019 and March 2020, with surgically diagnosed endometriosis, were included in this study. They received a treatment with 5 mg dydrogesterone administered orally twice daily for 21 days; from the 5th to 25th day of each menstrual cycle, for a total of 6 months. They were evaluated pre- and posttreatment in terms of their age, parity, and body mass index (BMI). Female Function Sexual Index (FSFI) and visual analogue scale (VAS) scores were recorded pre- and posttreatment
Sponsors
Kanuni Sultan Suleyman Training and Research Hospital
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No
Inclusion criteria
* no history of malignancies, * normal findings at gynecological examinations and transvaginal ultrasonography * normal uterine size, normal cervical smear results, * patients not use any contraception methods in the last 6 months
Exclusion criteria
* with a history of systemic and/or psychiatric diseases, * gynecological pathologies (myoma uteri, endometriosis, uterine anomalies, existing genital infections) * pelvic organ prolapse * pelvic surgeries
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The Effect of Dydrogesterone on Sexual Function | 6 months | In this study, we compare the fsfi(female sexual function index) questions and the scores before and after dihydrogestreone treatment in patients with endometriosis. We aim to measure the effect of dihydrogesterone in patients with endometriosis. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| The Effect of Dydrogesterone on Sexual Function in women with endometrioma | 6 months | In this study, we compare the fsfi(female sexual function index) questions and the scores before and after dihydrogestreone treatment in patients with endometriosis. We aim to measure the effect of dihydrogesterone in patients with endometriosis.(with and without endometrioma) |
Countries
Turkey (Türkiye)
Outcome results
None listed